Your browser doesn't support javascript.
loading
In-depth characterization of neuroradiological findings in a large sample of individuals with autism spectrum disorder and controls.
Ambrosino, Sara; Elbendary, Hasnaa; Lequin, Maarten; Rijkelijkhuizen, Dominique; Banaschewski, Tobias; Baron-Cohen, Simon; Bast, Nico; Baumeister, Sarah; Buitelaar, Jan; Charman, Tony; Crawley, Daisy; Dell'Acqua, Flavio; Hayward, Hannah; Holt, Rosemary; Moessnang, Carolin; Persico, Antonio M; Sacco, Roberto; San José Cáceres, Antonia; Tillmann, Julian; Loth, Eva; Ecker, Christine; Oranje, Bob; Murphy, Declan; Durston, Sarah.
Afiliación
  • Ambrosino S; University Medical Center Utrecht, Utrecht, the Netherlands. Electronic address: S.AmbrosinodiBruttopilo-3@umcutrecht.nl.
  • Elbendary H; Clinical Genetics Department, Human Genetics and Genome Research Division of the National Research Center, Cairo, Egypt.
  • Lequin M; Department of Radiology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Rijkelijkhuizen D; University Medical Center Utrecht, Utrecht, the Netherlands; Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands.
  • Banaschewski T; Department of Child and Adolescent Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • Baron-Cohen S; Autism Research Centre, Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom.
  • Bast N; Department of Child and Adolescent Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • Baumeister S; Department of Child and Adolescent Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • Buitelaar J; Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands.
  • Charman T; Department of Psychology, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.
  • Crawley D; Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology & Neuroscience, King's College, London, United Kingdom.
  • Dell'Acqua F; Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology & Neuroscience, King's College, London, United Kingdom.
  • Hayward H; Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology & Neuroscience, King's College, London, United Kingdom.
  • Holt R; Autism Research Centre, Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom.
  • Moessnang C; Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, University of Heidelberg, Mannheim, Germany.
  • Persico AM; Child and Adolescent Neuropsychiatry Program at Modena University Hospital, & Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy; Child Neuropsychiatry / Neurodevelopmental Disorders Unit, University "Campus Bio-Medico", Rome, Italy.
  • Sacco R; Child Neuropsychiatry / Neurodevelopmental Disorders Unit, University "Campus Bio-Medico", Rome, Italy.
  • San José Cáceres A; Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology & Neuroscience, King's College, London, United Kingdom; Instituto de Investigación Sanitaria Gregorio Marañón (IISGM), Madrid and CIBERSAM (Centro Investigación Biomédica en Red Salud Mental), Spain.
  • Tillmann J; Roche Pharma Research and Early Development, Neuroscience and Rare Diseases, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.
  • Loth E; Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology & Neuroscience, King's College, London, United Kingdom.
  • Ecker C; Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology & Neuroscience, King's College, London, United Kingdom; Department of Child and Adolescent Psychiatry, University Hospital, Goethe University, Frankfurt am Main, Germany.
  • Oranje B; Center for Neuropsychiatric Schizophrenia Research (CNSR) and Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research (CINS), Mental Health Centre Glostrup, University of Copenhagen, Glostrup, Denmark.
  • Murphy D; Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology & Neuroscience, King's College, London, United Kingdom.
  • Durston S; University Medical Center Utrecht, Utrecht, the Netherlands.
Neuroimage Clin ; 35: 103118, 2022.
Article en En | MEDLINE | ID: mdl-35868222
ABSTRACT

BACKGROUND:

Autism spectrum disorder (ASD) is a group of neurodevelopmental conditions associated with quantitative differences in cortical and subcortical brain morphometry. Qualitative assessment of brain morphology provides complementary information on the possible underlying neurobiology. Studies of neuroradiological findings in ASD have rendered mixed results, and await robust replication in a sizable and independent sample.

METHODS:

We systematically and comprehensively assessed neuroradiological findings in a large cohort of participants with ASD and age-matched controls (total N = 620, 348 ASD and 272 controls), including 70 participants with intellectual disability (47 ASD, 23 controls). We developed a comprehensive scoring system, augmented by standardized biometric measures.

RESULTS:

There was a higher incidence of neuroradiological findings in individuals with ASD (89.4 %) compared to controls (83.8 %, p = .042). Certain findings were also more common in ASD, in particular opercular abnormalities (OR 1.9, 95 % CI 1.3-3.6) and mega cisterna magna (OR 2.4, 95 % CI 1.4-4.0) reached significance when using FDR, whereas increases in macrocephaly (OR 2.0, 95 % CI 1.2-3.2), cranial deformities (OR 2.4, 95 % CI 1.0-5.8), calvarian / dural thickening (OR 1.5, 95 % CI 1.0-2.3), ventriculomegaly (OR 3.4, 95 % CI 1.3-9.2), and hypoplasia of the corpus callosum (OR 2.7, 95 % CI 1.1-6.3) did not survive this correction. Furthermore, neuroradiological findings were more likely to occur in isolation in controls, whereas they clustered more frequently in ASD. The incidence of neuroradiological findings was higher in individuals with mild intellectual disability (95.7 %), irrespective of ASD diagnosis.

CONCLUSION:

There was a subtly higher prevalence of neuroradiological findings in ASD, which did not appear to be specific to the condition. Individual findings or clusters of findings may point towards the neurodevelopmental mechanisms involved in individual cases. As such, clinical MRI assessments may be useful to guide further etiopathological (genetic) investigations, and are potentially valuable to fundamental ASD research.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trastorno del Espectro Autista / Discapacidad Intelectual Tipo de estudio: Diagnostic_studies / Qualitative_research / Risk_factors_studies Límite: Humans Idioma: En Revista: Neuroimage Clin Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trastorno del Espectro Autista / Discapacidad Intelectual Tipo de estudio: Diagnostic_studies / Qualitative_research / Risk_factors_studies Límite: Humans Idioma: En Revista: Neuroimage Clin Año: 2022 Tipo del documento: Article